P

Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And CompanyBiotechnology · 51-200 · B2B contacts & data

10 Decision makers
200 Employees
$11M Revenue
2019 Founded

Decision Makers at Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company

Total identified

10 decision makers identified 2 C-Level 3 VP 5 Heads
Preview available contacts
Decision maker Email Phone

Create a free Zeliq account to access their verified emails and direct phone numbers.

See 10 decision makers on Zeliq →

Organizational Chart of Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company

Roles identified within Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company's leadership team, based on public professional data.

Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company's Full Organizational Chart

Loading…

Get their contacts on Zeliq →

Job title Department People Action

Team Structure headcount by department

Research
9
Operations
8
Technical
8
Medical
3
Other
3
Consulting
2
Finance
2
Project Management
2

Funding

Last round Other · $125M
Total funding $145M (4 rounds)
Corporate Round N/A Jan 2019
Post-IPO Equity N/A Jul 2020
Post-IPO Equity $20M Aug 2020
Post-IPO Equity $125M Sep 2022

Companies similar to Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company

About Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company

Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company is a business specialised in Biotechnology, based in United States. Founded in 2019, the company counts about 200 employees. Within the wider Hospitals and Health Care sector, Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company focuses on the Biotechnology segment. Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company sells primarily to other businesses (B2B) rather than to end consumers. To date, Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company has completed 4 funding rounds totalling $145M. Annual revenue is estimated at around $11M. Use this page to review Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company's industry, headcount, location and hiring signals, and to reach verified B2B contacts before your next outreach.

Activity & Market

Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company operates in the Biotechnology segment, part of the broader Hospitals and Health Care sector. As a B2B company, Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company primarily serves business clients and professional organisations. In terms of structure, it is registered as “Public company”.

How to prospect Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company's departments

Research

With 9 people, this is the organisation's biggest team. Long cycles and rigorous methods: respect their pace and bring evidence, not hype.

Operations

With 8 people, this is the organisation's second pillar. Pitch measurable time savings and error reduction: the metrics this function is judged on.

Technical

This department counts 8 people. Developer experience and integration effort will make or break your pitch here.

Medical

3 people work in this department. Medical teams trust peer references: name comparable organisations you already serve.

Other

A team of 3 people. A cross-functional team where use cases vary: qualify the actual roles before tailoring your pitch.

Consulting

This department counts 2 people. These profiles sell advice for a living: come with a sharp point of view, not a generic pitch.

FAQ Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company

What industry does Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company operate in?

Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company operates in the Biotechnology industry, specifically in the Hospitals and Health Care category.

How many employees does Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company have?

Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company has approximately 200 employees (in the 51-200 range). This figure is an estimate to help qualify the account, not a legally certified number.

How do I find contacts at Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company?

Zeliq lets you identify decision makers at Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company, enrich their professional contact details (verified emails and direct phone numbers), and launch targeted multichannel prospecting sequences.

Where is Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company headquartered?

Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company is headquartered in United States.

What is the organizational chart of Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company?

Roles identified within Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company's organization include CEO, Founder, Senior Vice President People & Culture, Vice President Operations, Sr Director Process Plant Engineering, Director, Environmental Health and Radiation Safety. With Zeliq, you can enrich each of these roles with verified emails and direct phone numbers.

Why use this data before prospecting Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company?

Knowing Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company's industry, headcount, and business signals lets you personalise your outreach, prioritise high-potential accounts, and reach the right decision makers from the very first contact.